Global Solutions for Infectious Diseases
- Research works
- 44 ▲ 4% vs 2013–17
- Citations
- 1.6k 36.6 per fractional work
- Top-10% rate
- 30.6% record average 16.5%
- Open access
- 70% world 28%
Not ranked overall: Global Solutions for Infectious Diseases is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 14.6×. Every wedge is a field page.
- Immunology and Microbiology 14.6×
- Medicine 2.8×
- Health Professions 1.4×
- Biochemistry, Genetics and Molecular Biology 1.2×
- Decision Sciences 0.8×
- Economics, Econometrics and Finance 0.8×
- Computer Science 0.5×
- Psychology 0.5×
- Engineering 0.4×
- Business, Management and Accounting 0.4×
- Materials Science 0.3×
- Mathematics 0.3×
- Environmental Science 0.2×
- Social Sciences 0.2×
- Physics and Astronomy 0.2×
- Chemistry 0.1×
- Agricultural and Biological Sciences 0.1×
Which keywords describe research at Global Solutions for Infectious Diseases?
By fractional works in all years, weighted toward what it does more of than the world: Antiretroviral Therapy, Epidemiology, Immune Response, Vaccine, Antibodies, HIV, AIDS and Immune Activation.
- Therapeutic Antibodies
- Fc Receptors
- Vaccine Development
- Insulin Resistance
- Epitope Prediction
- COVID-19
- Liver Disease
- Influenza
- Glycosylation
- Antigen Presentation
- Nucleoside Analogues
- Hepatotoxicity
- Treatment
- Preexposure Prophylaxis
- Pathogenesis
- Pandemic
- Immune Activation
- HIV
- Vaccine
- Epidemiology
- Antiretroviral Therapy
- Immune Response
- Antibodies
- AIDS
- HIV Transmission
- HIV Infection
- Drug Resistance
- Stigma and Discrimination
- Viral Load
- Integrase Inhibitors
- Renal Toxicity
- Respiratory
- Immunity
- Virus
- Antiviral Therapy
- SARS-CoV-2
- Genetic Variation
- Peptide-MHC Binding
- Antibody Engineering
- Monoclonal Antibodies
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Antiretroviral Therapy10▲ 97×6 topics
- Epidemiology10▲ 5.5×35 topics
- Immune Response7▲ 27×10 topics
- Vaccine7▲ 38×9 topics
- Antibodies6▲ 148×2 topics
- HIV6▲ 105×4 topics
- AIDS4▲ 181×1 topic
- Immune Activation4▲ 103×1 topic
- HIV Transmission3▲ 75×2 topics
- Pandemic3▲ 14×4 topics
- HIV Infection3▲ 50×4 topics
- Pathogenesis3▲ 11×7 topics
- Drug Resistance2▲ 18×4 topics
- Preexposure Prophylaxis2▲ 99×1 topic
- Stigma and Discrimination2▲ 99×1 topic
- Treatment2▲ 4.2×8 topics
- Viral Load2▲ 81×2 topics
- Hepatotoxicity2▲ 55×2 topics
- Integrase Inhibitors2▲ 96×1 topic
- Nucleoside Analogues2▲ 96×1 topic
- Renal Toxicity2▲ 80×2 topics
- Antigen Presentation2▲ 38×2 topics
- Respiratory2▲ 38×2 topics
- Glycosylation2▲ 16×2 topics
- Immunity2▲ 10×5 topics
- Influenza2▲ 77×1 topic
- Virus2▲ 31×1 topic
- Liver Disease1▲ 23×3 topics
- Antiviral Therapy1▲ 20×3 topics
- COVID-191▲ 4.4×8 topics
- SARS-CoV-21▲ 19×5 topics
- Epitope Prediction1▲ 148×1 topic
- Genetic Variation1▲ 8.6×2 topics
- Insulin Resistance1▲ 5.8×3 topics
- Peptide-MHC Binding1▲ 148×1 topic
- Vaccine Development1▲ 8.7×5 topics
- Antibody Engineering1▲ 25×1 topic
- Fc Receptors1▲ 25×1 topic
- Monoclonal Antibodies1▲ 18×2 topics
- Therapeutic Antibodies1▲ 20×2 topics
Which research topics does Global Solutions for Infectious Diseases publish most on?
By volume in 2022–2025: HIV/AIDS Research and Interventions, HIV Research and Treatment, HIV-related health complications and treatments and Pneumonia and Respiratory Infections.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 HIV/AIDS Research and Interventions Infectious Diseases 1 works
- 2 HIV Research and Treatment Virology 1 works
- 3 HIV-related health complications and treatments Emergency Medicine 0 works
- 4 Pneumonia and Respiratory Infections Epidemiology 0 works
- 5 HIV/AIDS drug development and treatment Infectious Diseases 0 works
- 6 Bacterial Infections and Vaccines Microbiology 0 works
- 7 Tuberculosis Research and Epidemiology Infectious Diseases 0 works
- 8 Software Engineering Techniques and Practices Information Systems 0 works
- 9 Antibiotic Resistance in Bacteria Molecular Medicine 0 works
- 10 Technology Assessment and Management Safety, Risk, Reliability and Quality 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Global Solutions for Infectious Diseases's research output changed?
Output in 2018–2022 was 4% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in South San Francisco
- Sunesis (United States)
- Exelixis (United States)
- Kaiser Permanente South San Francisco Medical Center
- Cytokinetics (United States)
- Portola Pharmaceuticals (United States)
- NGM Biopharmaceuticals (United States)
- Rapt Therapeutics (United States)
- Atara Biotherapeutics (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.